Theleme Partners LLP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Theleme Partners LLP reported 9 stock positions worth $1.5 billion. Its top holding was Moderna (MRNA) at 27.2% of the portfolio, followed by Meta Platforms Class A (META, 17.2%) and Uber Technologies (UBER, 15.3%). Compared with Q4 2025, it opened 1 new position, sold out of 1, added to 6 and reduced 1. The biggest buy was a new position in Robinhood Markets Class A (HOOD) and the biggest sale an exit from Wells Fargo (WFC).
- Most Recent 13F
- Q2 2026
- Location
- London, X0
- CIK
- 0001511881
- Portfolio Value
- $1.5B (Q1 2026)
- SEC Filing
- 0000919574-26-003141 ↗ filed May 15, 2026
Holdings Value
Holdings 9 stocks · $1.5B
| MRNA Moderna Inc. | 27.24% | 8,048,245 | $408.9M | Reduce -0.4% |
| META Meta Platforms Inc. Class A | 17.19% | 451,075 | $258.1M | Add +4.6% |
| UBER Uber Technologies Inc. | 15.25% | 3,183,250 | $229.0M | Add +61.0% |
| TRU Transunion | 10.68% | 2,316,882 | $160.3M | Add +3.9% |
| AMZN Amazon.com Inc. | 10.21% | 735,979 | $153.3M | Add +7.6% |
| FLUT Flutter Entertainment PLC-Di | 6.56% | 966,041 | $98.5M | Add +7.8% |
| EFX Equifax Inc. | 6.49% | 541,088 | $97.4M | Add +6.9% |
| HOOD Robinhood Markets Inc. Class A | 5.29% | 1,145,000 | $79.3M | New |
| SIFY Sify Technologies-Spon ADR | 1.09% | 1,278,683 | $16.4M | No change |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
| HOOD Robinhood Markets Inc. Class A | New | 5.29% | +5.29 |
| UBER Uber Technologies Inc. | Add +61.0% | 15.25% | +4.74 |
| AMZN Amazon.com Inc. | Add +7.6% | 10.21% | −0.07 |
| EFX Equifax Inc. | Add +6.9% | 6.49% | −0.66 |
| META Meta Platforms Inc. Class A | Add +4.6% | 17.19% | −1.33 |
| TRU Transunion | Add +3.9% | 10.68% | −1.77 |
| FLUT Flutter Entertainment PLC-Di | Add +7.8% | 6.56% | −5.98 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $1.7B | MRNA, META, UBER, AMZN, TRU |
| Q1 2026 | 9 | $1.5B | MRNA, META, UBER, TRU, AMZN |
| Q4 2025 | 9 | $1.5B | META, MRNA, FLUT, TRU, WFC |
| Q3 2025 | 10 | $1.6B | META, WFC, MRNA, TRU, UBER |
| Q2 2025 | 10 | $1.6B | MRNA, WFC, META, TRU, FLUT |
| Q1 2025 | 12 | $1.3B | MRNA, AMZN, WFC, TRU, EFX |
| Q4 2024 | 11 | $1.5B | MRNA, BAC, WFC, AMZN, EFX |
| Q3 2024 | 10 | $1.7B | MRNA, SCHW, TRU, EFX, HRI |
| Q2 2024 | 8 | $2.0B | MRNA, SCHW, WFC, TRU, HRI |
| Q1 2024 | 7 | $1.8B | MRNA, SCHW, WFC, HRI, TRU |